Myelodysplastic Syndrome

PostMI syndrome Dressler's syndrome

DubinJohnson Syndrome and Rotor's Syndrome

Behet's Syndrome

Milkalkali syndrome

The Medical Minute: What is myelodysplastic syndrome?

Television journalist and host of "Good Morning America" Robin Roberts announced this week that she has myelodysplastic syndrome, or MDS, an uncommon blood and bone marrow disorder.

Apogenix myelodysplastic syndrome therapy wins FDA orphan drug designation

Clinical stage biopharmaceutical company Apogenix's Apocept (APG101) has won FDA orphan drug designation to treat myelodysplastic syndromes (MDS).

Myelodysplastic Syndrome Patients Treated With Deferasirox Show Beneficial Iron Reduction

Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syndrome, or MDS, a blood-related malignancy that invol...

Azacitidine induction helps stem-cell transplant for myelodysplastic syndrome

NEW YORK (Reuters Health) - Survival after allogeneic stem-cell transplantation for myelodysplastic syndrome (MDS) is just as good with pretransplant azacitidine as with standard -- but more toxic...

Telik receives Orphan status for Telintra for myelodysplastic syndrome

Telik, a clinical stage drug development company focused on developing small molecule drugs to treat cancer, was notified today that its product candidate, ezatiostat HCL (Telintra), has been granted...

Myelodysplastic Syndrome Linked to Abnormal Stem Cells

THURSDAY, July 5 (HealthDay News) -- As researchers suspected, abnormal bone marrow stem cells trigger the development of myelodysplastic syndromes, serious blood diseases that affect the bone marrow...

Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction, Moffitt says

(H. Lee Moffitt Cancer Center & Research Institute) Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syn...

EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms

Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z)-isomers of ON 01910·Na (Rigosertib®), a phase III clinical stage anti-cancer agent.

A stereoselective and efficient method for free radical addition of benzyl thiol to aryl acetylene in the presence of EtB-hexane has been developed for the synthesis of (Z) and (E)-styryl benzyl sulfi...

Case 27-2010.

A 73-year-old woman was seen in the cancer center at this hospital for management of a myelodysplastic syndrome. She had had anemia for 2 years, and a diagnosis of a myelodysplastic syndrome with isol...

A New ATRX Mutation in a Patient With Acquired α-Thalassemia Myelodysplastic Syndrome.

Acquired α-thalassemia (α-thal) myelodysplastic syndrome (ATMDS) is a rare acquired syndrome characterized by a somatic point mutation in the ATRX gene in patients with chronic myeloid disorders. We...

Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.

We describe long-term disease-free survival after unrelated donor bone marrow transplantation (BMT) for myelodysplastic syndrome (MDS) in 118 patients aged

Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia.

Patients with aplastic anemia (AA) or myelodysplastic syndrome (MDS) often have persistent severe neutropenia and are susceptible to infectious complications. We retrospectively reviewed the clinical...